probiotics
Stephen Daniells (William Reed Business Media Ltd.) discusses what emerged at Probiota Global 2022.
Can a mutual solution be found for probiotics in Europe? Legal analysis, dilemmas, solutions are the topics of the webinar by IPA Europe, 4 April 2022.
Researchers have found that combining a probiotic product with immunotherapy may boost anti-tumor responses in people with advanced kidney cancer.
Researchers have found that Lactobacilli could be used to treat common acne lesions, reducing the need for topical antibiotics.
The International Probiotics Association and the European Dairy Association are jointly asking to reinforce their involvement in the definition of the current view of probiotic products in Europe
Probiota Global 2022, 28-30 March, is the ideal place to gain the latest knowledge in the field of prebiotics, probiotics and the microbiome.
A high-fiber diet may improve melanoma patients’ response to immunotherapy. A new study published in Science claims.
Lactobacillus reuteri can protect against colorectal cancer through reuterin, one of its metabolites. A new study published in Cencer Cell claims
Bacterial spores of the probiotic Bacillus subtilis can prevent dangerous Enterococcus bacteria from invading the blood and causing systemic infections.
Dr. Raanan Shamir discusses the role that the intestinal microbiota plays in the development of celiac disease.
